SAMH
AIM

Shanda Asset Management Holdings’s AIM ImmunoTech AIM Stock Holding History

Shanda Asset Management Holdings’s Portfolio AIM Stock Details AIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-290
Closed -$72K – 116
2020
Q2 		$72K Buy
+290
New +$70.4K 0.01% 98

Other funds holding AIM

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SWM
SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Shanda Asset Management Holdings's AIM Position: Q3 2020 in Review

Shanda Asset Management Holdings sold out of AIM ImmunoTech (AIM) in Q3 2020, closing a stake of 290 shares — an estimated $72K sold.

Shanda Asset Management Holdings first reported a position in AIM in Q2 2020 and held it in 1 quarter. The position peaked at $72K in Q2 2020. 32 funds tracked by Wall St. Rank hold AIM as of Q3 2020.

  • Shanda Asset Management Holdings reported no remaining AIM ImmunoTech position as of Q3 2020 after selling out during the quarter.
  • Shanda Asset Management Holdings sold 290 AIM ImmunoTech shares in Q3 2020, an estimated $72K.
  • Shanda Asset Management Holdings first reported a position in AIM ImmunoTech in Q2 2020 and held it in 1 quarter.
  • Shanda Asset Management Holdings's AIM ImmunoTech position peaked at $72K in Q2 2020.
  • 32 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q3 2020.

Based on Shanda Asset Management Holdings's 13F filing for Q3 2020, filed 16 Nov 2020.